Intracranial Hypertension

In acute brain injury, prioritize immediate brain imaging and assessment for a surgically remediable process—intracranial hemorrhage, mass lesion, hydrocephalus, or diffuse edema—rather than waiting for lumbar puncture confirmation. Elevated ICP can reduce cerebral perfusion and contribute to secondary ischemic injury; contemporary neurocritical care targets commonly emphasize cerebral perfusion pressure of 60–70 mmHg. ScienceDirect+1ScienceDirectEvolving concepts in intracranial pressure monitoringPubMedIntracranial Hypertension - StatPearls - NCBI Bookshelf - NIH

Use invasive ICP monitoring when management depends on continuous ICP assessment, particularly in severe traumatic brain injury and in patients proceeding through escalating tiered therapy. ICP of at least 15 mmHg has been associated with adverse neurologic outcomes, although the measurement requires invasive monitoring. Nature+1NatureTiming of decompressive craniectomy and short-term outcomes in pediatric severe traumatic brain injury: a nationwide observational study in Germany | Scientific ReportsNatureDerivation, external and clinical validation of a deep ...

If documented or strongly suspected ICP elevation requires osmotherapy, use either hypertonic saline or mannitol according to hemodynamic context and local protocol. Mannitol can lower mean arterial pressure; hypertonic saline may better preserve or increase arterial pressure. A meta-analysis of five small unblinded randomized trials found a relative risk of 1.16 favoring hypertonic saline for ICP reduction, but the absolute difference in ICP reduction was not clinically significant. NEJM+1NEJMHypertonic Saline vs. Mannitol for Treating Elevated Intracranial Pressure | NEJM ClinicianWolters KluwerHypertonic saline versus mannitol for the... : Critical Care ...

For chronic or subacute intracranial hypertension, obtain brain MRI with and without contrast when feasible to assess for hydrocephalus, parenchymal mass, structural disease, and meningeal enhancement. CT may be the initial rapid study, but MRI provides more detailed evaluation of chronic intracranial causes. PubMed+1PubMedIntracranial Hypertension - StatPearls - NCBI Bookshelf - NIHPubMedIdiopathic intracranial hypertension in children: Diagnostic and management approach - PMC

Add MR venography or CT venography when IIH is being considered because cerebral venous sinus thrombosis must be excluded before labeling the syndrome idiopathic. Venous imaging can also demonstrate transverse sinus stenosis, an imaging association of IIH rather than a stand-alone diagnostic finding. PubMed+2PubMedIdiopathic Intracranial Hypertension Without Papilledema: A Case Emphasizing the Diagnostic Value of Optic Nerve Sheath UltrasoundPubMedIdiopathic intracranial hypertension in children: Diagnostic and management approach - PMCPubMedMRI findings as markers of idiopathic intracranial hypertension

After imaging has excluded a mass lesion, perform lumbar puncture with opening-pressure measurement and CSF analysis for infectious or inflammatory etiologies. In adults and nonsedated normal-weight children, opening pressure greater than 250 mm CSF is abnormal; in children, greater than 280 mm CSF is abnormal. Opening pressure alone is insufficient for a definite pseudotumor cerebri syndrome diagnosis. PubMed+1PubMedIntracranial Hypertension - StatPearls - NCBI Bookshelf - NIHPubMedPapilledema and Idiopathic Intracranial Hypertension

Structural intracranial hypertension is suggested by hydrocephalus, intraparenchymal lesion, mass effect, or abnormal meningeal enhancement on imaging. These findings redirect care toward the underlying lesion and away from diagnostic lumbar puncture until herniation risk is addressed. PubMed+1PubMedIntracranial Hypertension - StatPearls - NCBI Bookshelf - NIHPubMedIdiopathic intracranial hypertension in children: Diagnostic and management approach - PMC

Cerebral venous sinus thrombosis is the central imaging exclusion in suspected IIH. Obtain MRV when feasible or CTV when MRI cannot be performed; transverse sinus stenosis may accompany IIH, whereas venous thrombosis establishes a secondary cause. PubMed+1PubMedIdiopathic intracranial hypertension in children: Diagnostic and management approach - PMCPubMedMRI findings as markers of idiopathic intracranial hypertension

Infectious and inflammatory etiologies require CSF evaluation after safe imaging. The IIH diagnostic framework requires normal CSF composition and absence of another secondary cause; abnormal CSF should redirect evaluation to the identified inflammatory or infectious process rather than IIH. PubMed+2PubMedIntracranial Hypertension - StatPearls - NCBI Bookshelf - NIHPubMedIdiopathic intracranial hypertension in children: Diagnostic and management approach - PMCPubMedMRI findings as markers of idiopathic intracranial hypertension

Establish a definite IIH or pseudotumor cerebri syndrome diagnosis with the combined clinical, imaging, and lumbar puncture profile. Either papilledema or abducens palsy is required for a definite diagnosis; an elevated opening pressure alone is inadequate. PubMedPubMedPapilledema and Idiopathic Intracranial Hypertension

For IIH with papilledema, follow visual acuity and formal visual fields because progressive field loss can occur despite symptomatic headache improvement. In a reported management example, worsening visual fields after acetazolamide 500 mg twice daily led to dose escalation and optic nerve sheath fenestration within one week, followed by visual improvement. PubMedPubMedPapilledema and Idiopathic Intracranial Hypertension

Acetazolamide dosing is not standardized in the consensus guidance, and periodic serum electrolyte monitoring is recommended in licensing information without a consensus interval. Topiramate may be considered when its carbonic anhydrase activity, appetite suppression, and migraine efficacy are clinically useful; suggested escalation is 25 mg weekly to 50 mg twice daily. This use rests on limited IIH-specific comparative evidence. BMJBMJIdiopathic intracranial hypertension: consensus guidelines on management

In acute neurocritical illness, use continuous invasive ICP data when it changes escalation decisions and track cerebral perfusion alongside ICP. Sustained intracranial hypertension increases risk of secondary cerebral ischemia, which is why ICP-directed treatment must be coordinated with blood-pressure support and lesion control. Nature+1NatureTiming of decompressive craniectomy and short-term outcomes in pediatric severe traumatic brain injury: a nationwide observational study in Germany | Scientific ReportsScienceDirectEvolving concepts in intracranial pressure monitoring

In IIH, repeat ophthalmic assessments when papilledema is present or visual symptoms change. Visual field worsening should prompt treatment escalation even if headache improves, whereas recurrent headache in a shunted patient without papilledema should trigger evaluation for overdrainage or shunt dysfunction before elective revision. BMJ+1BMJIdiopathic intracranial hypertension: consensus guidelines on managementPubMedPapilledema and Idiopathic Intracranial Hypertension

When serial symptoms and examination remain discordant, revisit the etiologic diagnosis with MRI/MRV and safe lumbar puncture rather than attributing persistent symptoms to IIH on the basis of isolated radiologic signs or opening pressure. PubMed+2PubMedIdiopathic Intracranial Hypertension Without Papilledema: A Case Emphasizing the Diagnostic Value of Optic Nerve Sheath UltrasoundPubMedPapilledema and Idiopathic Intracranial HypertensionPubMedMRI findings as markers of idiopathic intracranial hypertension